DOI: 10.2337/db08-0753
A human type 1 diabetes susceptibility locus maps to chromosome 21q22.3
1Department of Biochemistry and Molecular Genetics, Objective.: The Type 1 Diabetes Genetics Consortium (T1DGC) has assembled and genotyped a large collection of multiplex families for the purpose of mapping genomic regions linked to type 1 diabetes. In the current study, we tested for evidence of loci associated with type 1 diabetes utilizing genome-wide linkage scan data and family-based association methods. Research Design and Methods: A total of 2,496 multiplex type 1 diabetes families were genotyped with a panel of 6,090 SNPs. Evidence of association to disease was evaluated by the pedigree disequilibrium test (PDT). Significant results were followed up by genotyping and analyses in two independent sets of samples: 2,214 parent-affected child trio families and a panel of 7,721 cases and 9,679 controls. Results: Three of the SNPs most strongly associated with type 1 diabetes localized to previously identified type 1 diabetes risk loci: INS, IFIH1, and KIAA0350. A fourth strongly associated SNP, rs876498 (P=1.0x10-4) occurred in the sixth intron of the UBASH3A locus at chromosome 21q22.3. Support for this disease association was obtained in two additional independent sample sets, type 1 diabetes families (OR=1.06, 95%CI=1.00-1.11, P=0.023) and cases and controls (OR=1.14, 95%CI=1.09-1.19, P=7.5x10-8). Conclusions: The T1DGC 6K SNP scan and follow-up studies reported here confirm previously reported type 1 diabetes associations at INS, IFIH1 and KIAA0350 and identify an additional disease association on chromosome 21q22.3 in the UBASH3A locus (OR=1.10, 95% CI=1.07-1.13, P=4.4x10-12). This gene and its flanking regions are now validated targets for further re-sequencing, genotyping and functional studies in type 1 diabetes.
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||